Trial Outcomes & Findings for Nutrigenomics: Personalizing Weight Loss for Obese Veterans (NCT NCT01859403)
NCT ID: NCT01859403
Last Updated: 2021-04-13
Results Overview
Our primary hypotheses are that more obese veterans in the MOVE! program will lose greater or equal to 5% of their weight if they receive personalized genomic information and a genomically-derived diet built around packaged meals when compared to veterans in the same program that receive usual care during MOVE! and packaged meals after 8 weeks.
COMPLETED
NA
51 participants
8 weeks
2021-04-13
Participant Flow
Participant milestones
| Measure |
Usual Care
Usual care for veterans as part of the MOVE! program
Usual Care: Patients receive the same dietary recommendation regardless of their genetic information
|
Personalized Genomics
Personalized genomics information from the FIT Test, Pathway Genomics
Personalized Genomics: A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
|
|---|---|---|
|
Primary Endpoint Measure
STARTED
|
21
|
30
|
|
Primary Endpoint Measure
COMPLETED
|
20
|
26
|
|
Primary Endpoint Measure
NOT COMPLETED
|
1
|
4
|
|
Secondary Endpoint Measure
STARTED
|
20
|
26
|
|
Secondary Endpoint Measure
COMPLETED
|
14
|
18
|
|
Secondary Endpoint Measure
NOT COMPLETED
|
6
|
8
|
Reasons for withdrawal
| Measure |
Usual Care
Usual care for veterans as part of the MOVE! program
Usual Care: Patients receive the same dietary recommendation regardless of their genetic information
|
Personalized Genomics
Personalized genomics information from the FIT Test, Pathway Genomics
Personalized Genomics: A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
|
|---|---|---|
|
Primary Endpoint Measure
Lost to Follow-up
|
0
|
2
|
|
Primary Endpoint Measure
Withdrawal by Subject
|
1
|
1
|
|
Primary Endpoint Measure
Physician Decision
|
0
|
1
|
|
Secondary Endpoint Measure
Withdrawal by Subject
|
6
|
8
|
Baseline Characteristics
Nutrigenomics: Personalizing Weight Loss for Obese Veterans
Baseline characteristics by cohort
| Measure |
Usual Care
n=20 Participants
Usual care for veterans as part of the MOVE! program
Usual Care: Patients receive the same dietary recommendation regardless of their genetic information
|
Personalized Genomics
n=26 Participants
Personalized genomics information from the FIT Test, Pathway Genomics
Personalized Genomics: A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
|
Total
n=46 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
54.6 years
STANDARD_DEVIATION 12.3 • n=99 Participants
|
48.4 years
STANDARD_DEVIATION 13.1 • n=107 Participants
|
51.1 years
STANDARD_DEVIATION 12.9 • n=206 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=99 Participants
|
10 Participants
n=107 Participants
|
13 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
17 Participants
n=99 Participants
|
16 Participants
n=107 Participants
|
33 Participants
n=206 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
2 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=99 Participants
|
5 Participants
n=107 Participants
|
8 Participants
n=206 Participants
|
|
Race (NIH/OMB)
White
|
13 Participants
n=99 Participants
|
12 Participants
n=107 Participants
|
25 Participants
n=206 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
4 Participants
n=99 Participants
|
7 Participants
n=107 Participants
|
11 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
20 participants
n=99 Participants
|
26 participants
n=107 Participants
|
46 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: 8 weeksOur primary hypotheses are that more obese veterans in the MOVE! program will lose greater or equal to 5% of their weight if they receive personalized genomic information and a genomically-derived diet built around packaged meals when compared to veterans in the same program that receive usual care during MOVE! and packaged meals after 8 weeks.
Outcome measures
| Measure |
Usual Care
n=20 Participants
Usual care for veterans as part of the MOVE! program
Usual Care: Patients receive the same dietary recommendation regardless of their genetic information
|
Personalized Genomics
n=26 Participants
Personalized genomics information from the FIT Test, Pathway Genomics
Personalized Genomics: A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
|
|---|---|---|
|
Number of Participants With Weight Loss of 5% or More at 8 Weeks
|
7 Participants
|
7 Participants
|
SECONDARY outcome
Timeframe: 24 weeksWe hypothesize that more veterans in the genomic group that lose greater or equal to 5% weight loss at 8 weeks will maintain this weight loss after 24 weeks compared to veterans in the usual care group.
Outcome measures
| Measure |
Usual Care
n=14 Participants
Usual care for veterans as part of the MOVE! program
Usual Care: Patients receive the same dietary recommendation regardless of their genetic information
|
Personalized Genomics
n=18 Participants
Personalized genomics information from the FIT Test, Pathway Genomics
Personalized Genomics: A set of single nucleotide polymorphisms in genes important for obesity, eating behaviors and exercise
|
|---|---|---|
|
Number of Participants With Weight Loss of 5% or More at 24 Weeks
|
5 Participants
|
7 Participants
|
Adverse Events
Usual Care
Personalized Genomics
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology
VA San Diego Health Sciences
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place